Table 3.

Absolute and Relative Cardiovascular Disease Mortality Rates, New York City, 2007–2017

	Males			Females
	CVD Deaths, n	Age-standardized CVD Mortality Rate, Per 1000 Person-years (95% CI)	Adjusted Rate Ratio for CVD Death vs Persons Without HIV (95% CI)	CVD Deaths, n	Age-standardized CVD Mortality Rate, Per 1000 Person-years (95% CI)	Adjusted Rate Ratio for CVD Death vs Persons Without HIV (95% CI)
Reference group: persons without HIV	106 261	3.55 (3.53–3.57)	1.00 (Ref.)	123 469	2.70 (2.68–2.71)	1.00 (Ref.)
Comparison 1: persons with HIV	2314	2.71 (2.53–2.88)	1.20 (1.15–1.26)	920	2.70 (2.41–2.98)	1.73 (1.62–1.85)
Comparison 2: persons with HIV, by HIV RNA level and CD4+ T-cell count
Suppressed HIV RNA and 500+ cells/uL	482	3.17 (2.67–3.67)	1.01 (.92–1.11)	196	2.01 (1.52–2.49)	1.25 (1.08–1.44)
Unsuppressed and 500+ cells/uL	86	7.45 (4.29–10.60)	1.55 (1.25–1.93)	32	2.73 (.74–4.72)	1.31 (.92–1.87)
Suppressed HIV RNA and <500 cells/uL	860	4.84 (4.35–5.33)	1.99 (1.85–2.14)	285	3.91 (3.21–4.60)	3.04 (2.69–3.44)
Unsuppressed and <500 cells/uL	469	9.05 (7.32–10.77)	3.41 (3.09–3.75)	250	8.46 (6.05–10.88)	5.64 (4.96–6.41)

Data were reported to the New York City Department of Health and Mental Hygiene by 31 December 2018. Rate ratios were adjusted for age, race/ethnicity, neighborhood poverty level, and calendar time.

Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HIV, human immunodeficiency virus; Ref., reference group.